Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment
dc.creator | Díez-Planelles C. | |
dc.creator | Sánchez-Lozano P. | |
dc.creator | Crespo M.C. | |
dc.creator | Gil-Zamorano J. | |
dc.creator | Ribacoba R. | |
dc.creator | González N. | |
dc.creator | Suárez E. | |
dc.creator | Martínez-Descals A. | |
dc.creator | Martínez-Camblor P. | |
dc.creator | Álvarez V. | |
dc.creator | Martín-Hernández R. | |
dc.creator | Huerta-Ruíz I. | |
dc.creator | González-García I. | |
dc.creator | Cosgaya J.M. | |
dc.creator | Visioli F. | |
dc.creator | Dávalos A. | |
dc.creator | Iglesias-Gutiérrez E. | |
dc.creator | Tomás-Zapico C. | |
dc.date.accessioned | 2020-09-02T22:17:19Z | |
dc.date.accessioned | 2022-11-08T20:22:47Z | |
dc.date.available | 2020-09-02T22:17:19Z | |
dc.date.available | 2022-11-08T20:22:47Z | |
dc.date.created | 2020-09-02T22:17:19Z | |
dc.date.issued | 2016 | |
dc.identifier | 108, , 102-110 | |
dc.identifier | 10436618 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4393 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144572 | |
dc.language | en | |
dc.publisher | Academic Press | |
dc.subject | Biomarker | |
dc.subject | Circulating microRNA | |
dc.subject | Huntington's disease | |
dc.subject | Metabolism | |
dc.subject | microRNA | |
dc.subject | Plasma | |
dc.subject | insulin | |
dc.subject | leptin | |
dc.subject | microRNA | |
dc.subject | microRNA 128 | |
dc.subject | microRNA 130b 3p | |
dc.subject | microRNA 22 5p | |
dc.subject | microRNA 223 3p | |
dc.subject | microRNA 223 5p | |
dc.subject | microRNA 228 3p | |
dc.subject | microRNA 338 3p | |
dc.subject | microRNA 361 5p | |
dc.subject | microRNA 425 5p | |
dc.subject | microRNA 628 3p | |
dc.subject | microRNA 877 5p | |
dc.subject | microRNA 942 | |
dc.subject | reelin | |
dc.subject | unclassified drug | |
dc.subject | biological marker | |
dc.subject | circulating microRNA | |
dc.subject | AATK gene | |
dc.subject | Article | |
dc.subject | cholesterol metabolism | |
dc.subject | controlled study | |
dc.subject | disease course | |
dc.subject | down regulation | |
dc.subject | exon | |
dc.subject | exosome | |
dc.subject | gene | |
dc.subject | gene expression profiling | |
dc.subject | gene overexpression | |
dc.subject | gene sequence | |
dc.subject | gene targeting | |
dc.subject | HIP1 gene | |
dc.subject | HTT gene | |
dc.subject | human | |
dc.subject | Huntington chorea | |
dc.subject | insulin release | |
dc.subject | intron | |
dc.subject | priority journal | |
dc.subject | SP1 gene | |
dc.subject | upregulation | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | blood | |
dc.subject | disease exacerbation | |
dc.subject | gene expression profiling | |
dc.subject | gene expression regulation | |
dc.subject | genetics | |
dc.subject | Huntington chorea | |
dc.subject | male | |
dc.subject | metabolism | |
dc.subject | middle aged | |
dc.subject | pathology | |
dc.subject | quality of life | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Biomarkers | |
dc.subject | Circulating MicroRNA | |
dc.subject | Disease Progression | |
dc.subject | Gene Expression Profiling | |
dc.subject | Gene Expression Regulation | |
dc.subject | Humans | |
dc.subject | Huntington Disease | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Quality of Life | |
dc.title | Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment | |
dc.type | Article |